Pediatric Neuroblastoma Treatment Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immunotherapy
1.2.3 Chemotherapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Neuroblastoma Treatment Market Perspective (2017-2028)
2.2 Pediatric Neuroblastoma Treatment Growth Trends by Region
2.2.1 Pediatric Neuroblastoma Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pediatric Neuroblastoma Treatment Historic Market Size by Region (2017-2022)
2.2.3 Pediatric Neuroblastoma Treatment Forecasted Market Size by Region (2023-2028)
2.3 Pediatric Neuroblastoma Treatment Market Dynamics
2.3.1 Pediatric Neuroblastoma Treatment Industry Trends
2.3.2 Pediatric Neuroblastoma Treatment Market Drivers
2.3.3 Pediatric Neuroblastoma Treatment Market Challenges
2.3.4 Pediatric Neuroblastoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Neuroblastoma Treatment Players by Revenue
3.1.1 Global Top Pediatric Neuroblastoma Treatment Players by Revenue (2017-2022)
3.1.2 Global Pediatric Neuroblastoma Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Pediatric Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatric Neuroblastoma Treatment Revenue
3.4 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio
3.4.1 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Neuroblastoma Treatment Revenue in 2021
3.5 Pediatric Neuroblastoma Treatment Key Players Head office and Area Served
3.6 Key Players Pediatric Neuroblastoma Treatment Product Solution and Service
3.7 Date of Enter into Pediatric Neuroblastoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Neuroblastoma Treatment Breakdown Data by Type
4.1 Global Pediatric Neuroblastoma Treatment Historic Market Size by Type (2017-2022)
4.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Type (2023-2028)
5 Pediatric Neuroblastoma Treatment Breakdown Data by Application
5.1 Global Pediatric Neuroblastoma Treatment Historic Market Size by Application (2017-2022)
5.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pediatric Neuroblastoma Treatment Market Size (2017-2028)
6.2 North America Pediatric Neuroblastoma Treatment Market Size by Type
6.2.1 North America Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022)
6.2.2 North America Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028)
6.2.3 North America Pediatric Neuroblastoma Treatment Market Share by Type (2017-2028)
6.3 North America Pediatric Neuroblastoma Treatment Market Size by Application
6.3.1 North America Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022)
6.3.2 North America Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028)
6.3.3 North America Pediatric Neuroblastoma Treatment Market Share by Application (2017-2028)
6.4 North America Pediatric Neuroblastoma Treatment Market Size by Country
6.4.1 North America Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022)
6.4.2 North America Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Pediatric Neuroblastoma Treatment Market Size (2017-2028)
7.2 Europe Pediatric Neuroblastoma Treatment Market Size by Type
7.2.1 Europe Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022)
7.2.2 Europe Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028)
7.2.3 Europe Pediatric Neuroblastoma Treatment Market Share by Type (2017-2028)
7.3 Europe Pediatric Neuroblastoma Treatment Market Size by Application
7.3.1 Europe Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022)
7.3.2 Europe Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028)
7.3.3 Europe Pediatric Neuroblastoma Treatment Market Share by Application (2017-2028)
7.4 Europe Pediatric Neuroblastoma Treatment Market Size by Country
7.4.1 Europe Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022)
7.4.2 Europe Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size (2017-2028)
8.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Type
8.2.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pediatric Neuroblastoma Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Application
8.3.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pediatric Neuroblastoma Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region
8.4.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pediatric Neuroblastoma Treatment Market Size (2017-2028)
9.2 Latin America Pediatric Neuroblastoma Treatment Market Size by Type
9.2.1 Latin America Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Pediatric Neuroblastoma Treatment Market Share by Type (2017-2028)
9.3 Latin America Pediatric Neuroblastoma Treatment Market Size by Application
9.3.1 Latin America Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Pediatric Neuroblastoma Treatment Market Share by Application (2017-2028)
9.4 Latin America Pediatric Neuroblastoma Treatment Market Size by Country
9.4.1 Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size (2017-2028)
10.2 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Type
10.2.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pediatric Neuroblastoma Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Application
10.3.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pediatric Neuroblastoma Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country
10.4.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 United Therapeutics
11.1.1 United Therapeutics Company Details
11.1.2 United Therapeutics Business Overview
11.1.3 United Therapeutics Pediatric Neuroblastoma Treatment Introduction
11.1.4 United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
11.1.5 United Therapeutics Recent Developments
11.2 Apeiron Biologics
11.2.1 Apeiron Biologics Company Details
11.2.2 Apeiron Biologics Business Overview
11.2.3 Apeiron Biologics Pediatric Neuroblastoma Treatment Introduction
11.2.4 Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
11.2.5 Apeiron Biologics Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Pediatric Neuroblastoma Treatment Introduction
11.3.4 Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
11.3.5 Pfizer Recent Developments
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Pediatric Neuroblastoma Treatment Introduction
11.4.4 Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
11.4.5 Bayer Recent Developments
11.5 Baxter
11.5.1 Baxter Company Details
11.5.2 Baxter Business Overview
11.5.3 Baxter Pediatric Neuroblastoma Treatment Introduction
11.5.4 Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
11.5.5 Baxter Recent Developments
11.6 Cellectar Biosciences
11.6.1 Cellectar Biosciences Company Details
11.6.2 Cellectar Biosciences Business Overview
11.6.3 Cellectar Biosciences Pediatric Neuroblastoma Treatment Introduction
11.6.4 Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
11.6.5 Cellectar Biosciences Recent Developments
11.7 MacroGenics
11.7.1 MacroGenics Company Details
11.7.2 MacroGenics Business Overview
11.7.3 MacroGenics Pediatric Neuroblastoma Treatment Introduction
11.7.4 MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
11.7.5 MacroGenics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Others
Table 5. Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Pediatric Neuroblastoma Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Pediatric Neuroblastoma Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Pediatric Neuroblastoma Treatment Market Share by Region (2017-2022)
Table 9. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Pediatric Neuroblastoma Treatment Market Share by Region (2023-2028)
Table 11. Pediatric Neuroblastoma Treatment Market Trends
Table 12. Pediatric Neuroblastoma Treatment Market Drivers
Table 13. Pediatric Neuroblastoma Treatment Market Challenges
Table 14. Pediatric Neuroblastoma Treatment Market Restraints
Table 15. Global Pediatric Neuroblastoma Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Pediatric Neuroblastoma Treatment Revenue Share by Players (2017-2022)
Table 17. Global Top Pediatric Neuroblastoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2021)
Table 18. Ranking of Global Top Pediatric Neuroblastoma Treatment Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Pediatric Neuroblastoma Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pediatric Neuroblastoma Treatment Product Solution and Service
Table 22. Date of Enter into Pediatric Neuroblastoma Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type (2017-2022)
Table 26. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type (2023-2028)
Table 28. Global Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Pediatric Neuroblastoma Treatment Revenue Share by Application (2017-2022)
Table 30. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Pediatric Neuroblastoma Treatment Revenue Share by Application (2023-2028)
Table 32. North America Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 62. United Therapeutics Company Details
Table 63. United Therapeutics Business Overview
Table 64. United Therapeutics Pediatric Neuroblastoma Treatment Product
Table 65. United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)
Table 66. United Therapeutics Recent Developments
Table 67. Apeiron Biologics Company Details
Table 68. Apeiron Biologics Business Overview
Table 69. Apeiron Biologics Pediatric Neuroblastoma Treatment Product
Table 70. Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)
Table 71. Apeiron Biologics Recent Developments
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Pediatric Neuroblastoma Treatment Product
Table 75. Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)
Table 76. Pfizer Recent Developments
Table 77. Bayer Company Details
Table 78. Bayer Business Overview
Table 79. Bayer Pediatric Neuroblastoma Treatment Product
Table 80. Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)
Table 81. Bayer Recent Developments
Table 82. Baxter Company Details
Table 83. Baxter Business Overview
Table 84. Baxter Pediatric Neuroblastoma Treatment Product
Table 85. Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)
Table 86. Baxter Recent Developments
Table 87. Cellectar Biosciences Company Details
Table 88. Cellectar Biosciences Business Overview
Table 89. Cellectar Biosciences Pediatric Neuroblastoma Treatment Product
Table 90. Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)
Table 91. Cellectar Biosciences Recent Developments
Table 92. MacroGenics Company Details
Table 93. MacroGenics Business Overview
Table 94. MacroGenics Pediatric Neuroblastoma Treatment Product
Table 95. MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)
Table 96. MacroGenics Recent Developments
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Neuroblastoma Treatment Market Share by Type: 2021 VS 2028
Figure 2. Immunotherapy Features
Figure 3. Chemotherapy Features
Figure 4. Others Features
Figure 5. Global Pediatric Neuroblastoma Treatment Market Share by Application: 2021 VS 2028
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Pediatric Neuroblastoma Treatment Report Years Considered
Figure 10. Global Pediatric Neuroblastoma Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Pediatric Neuroblastoma Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Pediatric Neuroblastoma Treatment Market Share by Region: 2021 VS 2028
Figure 13. Global Pediatric Neuroblastoma Treatment Market Share by Players in 2021
Figure 14. Global Top Pediatric Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Pediatric Neuroblastoma Treatment Revenue in 2021
Figure 16. North America Pediatric Neuroblastoma Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Pediatric Neuroblastoma Treatment Market Size Market Share by Type (2017-2028)
Figure 18. North America Pediatric Neuroblastoma Treatment Market Size Market Share by Application (2017-2028)
Figure 19. North America Pediatric Neuroblastoma Treatment Market Size Share by Country (2017-2028)
Figure 20. United States Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Pediatric Neuroblastoma Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Pediatric Neuroblastoma Treatment Market Size Market Share by Type (2017-2028)
Figure 24. Europe Pediatric Neuroblastoma Treatment Market Size Market Share by Application (2017-2028)
Figure 25. Europe Pediatric Neuroblastoma Treatment Market Size Share by Country (2017-2028)
Figure 26. Germany Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Pediatric Neuroblastoma Treatment Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Pediatric Neuroblastoma Treatment Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Pediatric Neuroblastoma Treatment Market Size Share by Region (2017-2028)
Figure 36. China Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Pediatric Neuroblastoma Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Pediatric Neuroblastoma Treatment Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Pediatric Neuroblastoma Treatment Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Pediatric Neuroblastoma Treatment Market Size Share by Country (2017-2028)
Figure 46. Mexico Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Pediatric Neuroblastoma Treatment Market Size Share by Country (2017-2028)
Figure 52. Turkey Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Pediatric Neuroblastoma Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. United Therapeutics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)
Figure 56. Apeiron Biologics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)
Figure 57. Pfizer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)
Figure 58. Bayer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)
Figure 59. Baxter Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)
Figure 60. Cellectar Biosciences Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)
Figure 61. MacroGenics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Industry Market Size
